Hostname: page-component-6766d58669-zlvph Total loading time: 0 Render date: 2026-05-17T20:34:01.062Z Has data issue: false hasContentIssue false
  • English
  • Français

Correction

Published online by Cambridge University Press:  02 January 2018

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Correction
Information
Advances in Psychiatric Treatment , Volume 17 , Issue 2 , March 2011 , pp. 158
Copyright
Copyright © The Royal College of Psychiatrists, 2011 

In Table 5 of the above, the entry in the last cell of the Olanzapine row should read 13. The corrected table appears below.

TabLE 5

Numbers needed to treat (NNT) for all-cause discontinuation for the Tiihonen studya

Comparator
Clozapine Olanzapine Perphenazine Risperidone Haloperidol Depot perphenazine
Primary Clozapine 6 2 4 2 15
Olanzapine −6 2 8 2 13
Perphenazine −2 −2 −4 5 −2
Risperidone −4 −8 4 2 −4
Haloperidol −2 −2 −5 −2 −2
Perphenazine depot −15 −13 2 4 2
Figure 0

TabLE 5 Numbers needed to treat (NNT) for all-cause discontinuation for the Tiihonen studya

Submit a response

eLetters

No eLetters have been published for this article.